
Am Fam Physician. 2025;111(3):263-264
Author disclosure: No relevant financial relationships.

Drug | Dosage | Dose form | Cost* |
---|---|---|---|
Berdazimer (Zelsuvmi) | Apply once daily for up to 12 weeks | Topical gel | $700 |
Berdazimer (Zelsuvmi) is a topical, nitric oxide–releasing agent that is theorized to treat molluscum contagiosum through antiviral and immunomodulatory properties.1 It is labeled for use in adults and children older than 1 year.2 Berdazimer consists of two components: the active ingredient, berdazimer sodium, binds nitric oxide, and a hydrogel acts as a proton donor. Combining these two components before application forms the therapeutic agent that releases nitric oxide from the berdazimer sodium polymer in a controlled, localized, topical application.1
Subscribe
From $165- Immediate, unlimited access to all AFP content
- More than 130 CME credits/year
- AAFP app access
- Print delivery available
Issue Access
$59.95- Immediate, unlimited access to this issue's content
- CME credits
- AAFP app access
- Print delivery available